Average Volume: 498,316
Volume % Change: 337% >>5 Rocket Stocks to Buy After Last Week's Bounce From a technical perspective, YY is ripping higher here and breaking out above some near-term overhead resistance levels at $29.01 to $30.09 with heavy upside volume. This move has started to push shares of YY into all-time high territory, which is bullish technical price action. Traders should now look for long-biased trades in YY as long as it's trending above either of those key breakout levels at $30.09 or above $29.01 with strong upside volume flows. I would consider any upside volume day that registers near or above its three-month average action of 498,316 shares as bullish. If YY can maintain this trend, then this stock will continue to trend into all-time high territory. Some possible upside targets are $35 to $40. Celldex Therapeutics Celldex Therapeutics ( CLDX) is a biopharmaceutical company focused on the development and commercialization of several immunotherapy technologies for the treatment of cancer and other difficult-to-treat diseases. This stock closed up 4.9% at $15.29 in recent trading. Today's Volume: 2.57 million
Average Volume: 1.53 million
Volume % Change: 216% >>5 Stocks Insiders Love Right Now From a technical perspective, CLDX is gapping sharply higher here and printing new 52-week highs with above-average volume. This move has firmly pushed shares of CLDX into breakout territory, since the stock has trended well above some near-term overhead resistance levels at $13.98 to $14.09. Traders should now look for long-biased trades in CLDX as long as it's trending above today's low of $14.74 or above $13.98 with strong upside volume flows. I would consider any upside volume day that registers near or above its three-month average action of 1.53 million shares. If CLDX can maintain that move, then this stock will set up to enter new 52-week-high territory above $15.71, which is bullish technical price action. Some possible upside targets off that move are $17 to $20.